Castle Biosciences, Inc. Share Price
Stocks
CSTL
US14843C1053
Medical Equipment, Supplies & Distribution
|
Market Closed -
Nasdaq
21:00:00 04/09/2026 BST
|
5-day change | 1st Jan Change | ||
| 32.91 USD | +0.80% |
|
-1.76% | -15.40% |
| 08-27 | Castle Biosciences Insider Sold Shares Worth $317,112, According to a Recent SEC Filing | MT |
| 08-17 | Castle Biosciences Gets Approval for Dual Listing on Nasdaq Texas | MT |
| Market Cap | 1.01B 865M 814M 744M 1.39B 94.92B 1.39B 9.62B 3.73B 48.7B 3.78B 3.69B 157B | P/E 2026 * |
-25.9x | P/E 2027 * | -33.3x |
|---|---|---|---|---|---|
| Enterprise Value | 1.01B 865M 814M 744M 1.39B 94.92B 1.39B 9.62B 3.73B 48.7B 3.78B 3.69B 157B | EV / Sales 2026 * |
2.7x | EV / Sales 2027 * | 2.46x |
| Free-Float |
97.56% | Yield 2026 * |
-
| Yield 2027 * | - |
| Markets | Quality | ||
|---|---|---|---|
Nasdaq
| CSTL | Delayed | |
CBOE
| CSTL | Real-time | |
|
Tradegate
| 086 | Real-time | |
|
Deutsche Boerse AG
| 086 | Delayed | |
|
Deutsche Boerse AG
| 086 | End-of-day quote |
Last Transcript : Castle Biosciences, Inc.
| 1 day | +0.80% | ||
| 1 week | -1.76% | ||
| Current month | -0.36% | ||
| 1 month | +8.26% | ||
| 3 months | +56.64% | ||
| 6 months | +17.91% | ||
| Current year | -15.40% |
| 1 week | 31.98 |  | 34.73 |
| 1 month | 28.72 | | 35.2 |
| Current year | 17.72 | | 44.28 |
| 1 year | 17.72 | | 44.28 |
| 3 years | 12.07 | | 44.28 |
| 5 years | 9.26 | | 78.58 |
| 10 years | 9.26 | | 107.69 |
| Manager | Title | Age | Since |
|---|---|---|---|
Derek Maetzold
CEO | Chief Executive Officer | 64 | 31/08/2007 |
Franklin Stokes
DFI | Director of Finance/CFO | 56 | 30/11/2017 |
Johnson Clare
CTO | Chief Tech/Sci/R&D Officer | - | 30/06/2021 |
| Director | Title | Age | Since |
|---|---|---|---|
Derek Maetzold
BRD | Director/Board Member | 64 | 31/08/2007 |
Daniel Bradbury
CHM | Chairman | 64 | 31/08/2014 |
G. Cole
BRD | Director/Board Member | 70 | 05/12/2018 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 01/09/26 | Exercice | Chief Operating Officer | 12,456 | 0.0411% | ||
| 31/08/26 | Sell | Executive/Senior Manager | -1,730 | 0.0057% | ||
| 28/08/26 | Exercice | Founder | 43,416 | 0.1431% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +0.80% | -1.76% | +39.69% | +72.12% | 1.01B | |
| +0.23% | -0.06% | +168.44% | +357.12% | 21.66B | |
| -2.24% | -1.33% | -37.24% | -20.96% | 10.16B | |
| -0.90% | +1.80% | +348.78% | +19.38% | 8.16B | |
| -0.99% | -2.18% | -28.06% | - | 7.08B | |
| -0.01% | +0.20% | +84.42% | +52.87% | 6.59B | |
| +2.34% | -1.27% | -20.74% | -15.41% | 6.03B | |
| -1.82% | -1.64% | -8.48% | -20.67% | 4.33B | |
| -0.62% | -0.38% | +74.99% | +85.77% | 4.22B | |
| +1.82% | -0.27% | -18.67% | -28.71% | 2.81B | |
| Average | -0.14% | -0.56% | +60.31% | +55.72% | 7.21B | |
| Weighted average by Cap. | -0.31% | -0.28% | +91.84% | +126.23% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 373M 321M 302M 276M 516M 35.21B 517M 3.57B 1.38B 18.06B 1.4B 1.37B 58.19B | 409M 352M 331M 303M 566M 38.66B 568M 3.92B 1.52B 19.83B 1.54B 1.5B 63.89B |
| Net income | -38.03M -32.73M -30.79M -28.13M -52.62M -3.59B -52.76M -364M -141M -1.84B -143M -140M -5.94B | -27.75M -23.88M -22.47M -20.52M -38.4M -2.62B -38.5M -265M -103M -1.34B -104M -102M -4.33B |
| Net Debt | - | - |
| Date | Price | Change | Volume |
|---|---|---|---|
| 04/09/26 | US$32.91 | +0.80% | 187,725 |
| 03/09/26 | US$32.65 | -2.30% | 268,012 |
| 02/09/26 | US$33.42 | -0.06% | 200,265 |
| 01/09/26 | US$33.44 | +1.24% | 396,179 |
| 31/08/26 | US$33.03 | -1.40% | 258,005 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- CSTL Stock
Select your edition
All financial news and data tailored to specific country editions
